| CLIENT NAME | DEAL TYPE | ACTION | DATE | AVG. PRICE | QUANTITY | EXCHANGE |
|---|
| Financials( ₹ in Cr) | J K Pharmachem Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Divis Laboratories Ltd | Dr Reddys Laboratories Ltd |
|---|---|---|---|---|---|
| Price | 0.00 | 1,505.30 | 1,407.45 | 3,959.95 | 6,242.75 |
| % Change | 0 | -0.98 | 0.09 | 3.02 | 0.39 |
| Mcap ₹ Cr | 0.00 | 361,171.90 | 113,632.87 | 105,124.40 | 104,140.31 |
| Revenue TTM ₹ Cr |
| Date | Action Type | Ratio |
|---|---|---|
| No data found |
Jointly promoted by J K Industries and TIDCO, J K Pharmachem manufactures drugs and pharmaceuticals. It entered the capital market in Oct.`94 to part-finance the setting up of a plant to manufacture 1250 MMU P.a of pencillin-G, based on a microbial strain from the technical collaborators -- IGC (Cyprus), Cyprus -- a wholly-owned subsidiary of ICN Galenika. Commercial production at this plant commenced in Oct.`95. The company has a tie-up with ICN Galenika, part of the ICN Pharmaceuticals group (one of the pioneering manufacturers of pencillin-G), to set up a 1250-mmu capacity plant. It has already produced international standard penicillin with Indian raw materials, at its collaborator`s plant which is among the best in the world. In addition, J K Pharmachem had set-up its own R&D activity well in advance for future development in the field of bio-technology. A pilot plant is also being established for this purpose at Cuddalore, Tamilnadu. The company also plans to diversify into speciality fermentation products. It has also started production of Penicillin-V and is the only one in India to produce this bulk active. During 1999-2000, the company started the production of Penicillin V and is the only producer of this important bulk active in India. The accumulated losses of the company having exceeded 50% of the peak networth of the company in the immediately preceding four financial years, the company took the necessary steps of SICA, 1985. The company developed an in-house and launched viz JKZyme, an environment new product of paper & pulp. Commercial trails are under way in India and abroad. The company has produced 1192 MMU of Penicillin-G during the financial year 2003-04 and retained its status as the second largest producer with a market share of 24%.
A-7 SIPCOT Industrial Complex, South Arcot Dist Vallalar, Cuddalore, Tamil Nadu, 607005
| Tel | : | 91-04142-239016-20 |
Cameo Corporate Services Ltd
| AGM Date (Month) | : | Jan |
| Face Value Equity Shares | : | 10 |
| Market Lot Equity Shares | : | 1 |
| BSE Code | : | 500218 |
| NSE Code | : | JKPHARMA |
| Book Closure Date (Month) | : | Jan |
| BSE Group | : | B |
| ISIN | : | INE335C01018 |
FAQ’s on J K Pharmachem Ltd SharesYou can buy J K Pharmachem Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy J K Pharmachem Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of the closing price of J K Pharmachem Ltd was ₹ -.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of , the market cap of J K Pharmachem Ltd stood at ₹ 0.00.
The latest PE ratio of J K Pharmachem Ltd as of is 0
The latest PB ratio of J K Pharmachem Ltd as of is 0
The 52-week high of J K Pharmachem Ltd share price is ₹ 0 while the 52-week low is ₹ 0
Invest
